CV Therapeutics, Inc.
CV Therapeutics, Inc., provides an activity update
Published in Health Business Week, June 8th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at CV Therapeutics, Inc.
Report 1: CV Therapeutics, Inc. (NASDAQ:CVTX) announced that the Journal of the American College of Cardiology (JACC) has published data from the Ranolazine Open Label Experience (ROLE) program, which showed long-term therapy with Ranexa(R) (ranolazine extended-release tablets) to be safe and well tolerated in patients with chronic stable angina who completed one of two phase 3 clinical trials, and enrolled in the ROLE program.
These data also suggest no...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
Source: Health Business Week (2007-06-08)
More Articles from Health Business Week
- Accuro Healthcare Solutions Inc.
Accuro Healthcare Solutions Inc. Announces Agreement with Tenet Healthcare to Provide Revenue Management Tools - ACS, Inc.
ACS Healthcare Expert Will Saunders Appointed to Electronic Health Information Exchange Taskforce - Actavis Group
Actavis Launches Finasteride 5mg Tablets in the U.S. - Addiction Medicine
New DVD and Booklet Help Parents and Educators Talk with Kids about Prescription Drug Misuse - Addiction Medicine
Study of Missouri Dads-to-Be Holds Promise for Ending Addiction to Tobacco, According to Schaller Anderson - Adept Technology, Inc.
Adept Technology Selected by Integrated BioSciences, Inc. as Robotics Partner for Standard Medical Platform - More from this issue of Health Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
